Invention Grant
US09480724B2 Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, LDL cholesterol, blood glucose, C-reactive protein, and leptin levels and increasing adiponectin levels
有权
治疗和预防代谢综合征并降低总胆固醇，低密度脂蛋白胆固醇，血糖，C-反应蛋白和瘦素水平和增加脂连蛋白水平
- Patent Title: Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, LDL cholesterol, blood glucose, C-reactive protein, and leptin levels and increasing adiponectin levels
- Patent Title (中): 治疗和预防代谢综合征并降低总胆固醇，低密度脂蛋白胆固醇，血糖，C-反应蛋白和瘦素水平和增加脂连蛋白水平
-
Application No.: US14242749Application Date: 2014-04-01
-
Publication No.: US09480724B2Publication Date: 2016-11-01
- Inventor: Julius Enyoug Oben
- Applicant: Julius Enyoug Oben
- Agency: Partners Law Group, Inc.
- Agent Steve P. Hassid
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/185
Abstract:
In one embodiment, a method is provided for lowering C-reactive protein levels in a mammal. The method comprises administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to reduce C-reactive protein levels in the mammal. Other embodiments include, among other things, lowering leptin levels, increasing adiponectin levels, reducing body weight, decreasing LDL and total cholesterol levels, increasing fat loss, and reducing waist size in a mammal using administering a composition containing an effective amount of Irvingia gabonensis.
Public/Granted literature
Information query
